ROP:SWX
Roche Holding AG Genussscheine
CHFÂ 391.70
arrow_downward
-1.06%(-4.20) 1D
Nov 5, 5:30:29 PM GMT+1 · CHF
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ROP...
Open
CHFÂ 394.40
High
CHFÂ 395.90
Low
CHFÂ 390.20
Mkt. cap
317.59B
Avg. vol.
982.27K
Volume
1.28M
Dividend
2.50%
Quarterly dividend
CHFÂ 2.45
Ex-dividend date
Mar 27, 2025
P/E ratio
25.56
52-wk high
CHFÂ 405.90
52-wk low
CHFÂ 291.00
EPS
CHFÂ 15.33
Shares outstanding
702.56M
No. of employees
113K
Open
CHFÂ 394.40
High
CHFÂ 395.90
Low
CHFÂ 390.20
Mkt. cap
317.59B
Avg. vol.
982.27K
Volume
1.28M
Dividend
2.50%
Quarterly dividend
CHFÂ 2.45
Ex-dividend date
Mar 27, 2025
P/E ratio
25.56
52-wk high
CHFÂ 405.90
52-wk low
CHFÂ 291.00
EPS
CHFÂ 15.33
Shares outstanding
702.56M
No. of employees
113K
News stories
From web sources and news partners
marketscreener.com
·
15 minutes ago
Gold drops over 1% on higher oil prices; US payrolls data in focus
TradingView
·
47 minutes ago
S&P 500 clings to 200-Day SMA as support zone comes into focus
Moomoo
·
31 minutes ago
Dow Jones Top Financial Services Headlines at 12 AM ET: Hong Kong Exchange Operator's Net Profit Slips as Trading Activity Cools | Hedge ...
www.tokenpost.com
·
1 hour ago
S&P 500 Firms Lose Nearly $3 Trillion as Gold Advances
Profile
F. Hoffmann-La Roche AG, commonly known as Roche, is a Swiss multinational holding healthcare company that operates worldwide under two divisions: Pharmaceuticals and Diagnostics. Its holding company, Roche Holding AG, has shares listed on the SIX Swiss Exchange. The company headquarters are located in Basel.
Roche is the fifth-largest pharmaceutical company in the world by revenue and the leading provider of cancer treatments globally. In 2023, the company’s seat in the Forbes Global 2000 was 76.
The company owns the American biotechnology company Genentech, which is a wholly owned independent subsidiary, and the Japanese biotechnology company Chugai Pharmaceuticals, as well as the United States–based companies Ventana and Foundation Medicine. Roche's revenues during fiscal year 2020, were 58.32 billion Swiss francs. Descendants of the founding Hoffmann and Oeri families own slightly over half of the bearer shares with voting rights, with Swiss pharma firm Novartis owning a further third of its shares until 2021.
F. Hoffmann-La Roche is a full member of the European Federation of Pharmaceutical Industries and Associations. Wikipedia
About Roche Holding AG Genussscheine
CEOThomas Schinecker
Employees113K
FoundedOct 1, 1896
HeadquartersBasel, Basel City, Switzerland
SectorHealth Care
IndustryPharmaceutical industry
Websiteroche.com